Idiopathic Orbital Inflammation Underlying Drug-Associated Thyroid Eye Disease
DOI:
https://doi.org/10.17161/kjm.vol15.18210Keywords:
Alemtuzumab, Thyroid, Graves', lymphoma, inflammatoryMetrics
Metrics Loading ...
Downloads
Published
2022-10-24
Issue
Section
Case Reports
License
Copyright (c) 2022 Hythem Abouodah, Stephen L. Ambrose, M.D., Jordan E. Miller, M.D., Mary K. Mitchell, Jason A. Sokol, M.D.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
All articles in the Kansas Journal of Medicine are licensed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND 4.0).
How to Cite
Abouodah, H., Ambrose, S. L., Miller, J. E., Mitchell, M. K., & Sokol, J. A. (2022). Idiopathic Orbital Inflammation Underlying Drug-Associated Thyroid Eye Disease. Kansas Journal of Medicine, 15(3), 380-381. https://doi.org/10.17161/kjm.vol15.18210